Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603740 | PMC |
| http://dx.doi.org/10.1016/j.phrs.2021.105907 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761].
Pharmacol Res
December 2021
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, China; KingMed Virology Diagnostic & Translational Center, China. Electronic address:
Corrigendum to "Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps" [Am. J. Otolaryngol. 2020 Jan - Feb;41(1):102311].
Am J Otolaryngol
May 2020
Department of Otorhinolaryngology-Head and Neck Surgery, Huashan Hospital North of Fudan University, Shanghai, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!